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Abstract
Background: Seriously ill children suffer from numerous symptoms at the end of their lives, including pain, anxiety,
and restricted communication. There are currently no comprehensive overviews of which health interventions have
proven benefits and which have proven detrimental effects on the quality of life of children in an end-of-life
context. In order to identify potential quality indicators to eventually improve care, a systematic review of available
evidence is needed. The aim of the current systematic review will be to make an overview of the influence of
health interventions on associated outcomes related to quality of life at the end of life in seriously ill children.
Methods: A systematic search will be conducted in MEDLINE, Embase, CENTRAL, CINAHL, and Web of Science. We
will include quantitative empirical designs looking into the influence of a health intervention on (proxies of) quality
of life at the end of life in seriously ill children. Three independent authors will review titles and abstracts and
screen full texts against eligibility criteria. One reviewer will carry out full data extraction and quality assessment,
and a 20% random sample will be extracted and assessed by two independent reviewers. We will use the QualSyst
Tool for assessment of the quality of the included studies (QualSyst Tool) for quality assessment; overall strength of
the body of evidence will be assessed using the Grading of Recommendations Assessment, Development, and
Evaluation (GRADE) approach. An overview table of health interventions will be discussed through narrative
synthesis. Should sufficient homogeneous publications arise, we will perform meta-analyses with a random-effects
model. Our protocol adheres to the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols
(PRISMA-P) checklist for study protocols.
Discussion: As part of a larger project, we will use the results of this review to identify a first set of quality indicators
for the care for children at the end of life. Reviewing the current span of evidence and identifying research gaps will
uncover future research priorities into the care for children at the end of life.
Systematic review registration: PROSPERO CRD42018105109
Keywords: Children, Pediatrics, End of life, Seriously ill, Quality of life, Health intervention, Review, Systematic,
Symptom control
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: veerle.piette@vub.be
1End-of-Life Care Research Group, Vrije Universiteit Brussel & Ghent
University, Brussels/Ghent, Belgium
2Department of Family Medicine and Chronic Care, Vrije Universiteit Brussel,
Laarbeeklaan 103, 1090 Brussels, Belgium
Full list of author information is available at the end of the article
Piette et al. Systematic Reviews           (2019) 8:165 
https://doi.org/10.1186/s13643-019-1059-8
Background
Despite medical advancements and intensive research
into therapy and treatment, some children’s illnesses
such as cancer, neurological conditions, and other pro-
gressive, life-threatening disorders remain incurable even
in developed countries. Worldwide, children with pro-
gressive, serious illnesses estimate one-third of yearly
child mortalities [1]. International mortality rates for
these disorders vary between hundreds of children per
year for small-population countries and thousands of
children per year for largely populated countries [1].
Moreover, prevalence of children dying due to serious
illness seems to be on the rise: an increase of 25 to 32
per 10,000 population was reported in England between
2000 and 2010 [2].
The symptom burden at the end of life in these chil-
dren is found to be very high [3–6]. Symptoms and care
needs at the end of life have been studied extensively for
malignancies [3, 5, 6], with pain, fatigue, dyspnea, and
anorexia often cited, but less so for other disease trajec-
tories [4], where the scarce research seems to show dis-
tinct symptoms at the end of life such as numbness and
breathing problems [4]. The most frequently reported
symptoms are not only physical, such as pain and dys-
pnea, but also psychological, such as nervousness and
worrying [4–6]. Due to high symptom burden, many re-
searchers and clinicians advocate more extensive devel-
opment of supportive and end-of-life care for this
population.
According to the American Academy of Pediatrics,
family-centered, child- and disease-specific supportive
care for children should be broadly available, and well-
integrated within the disease trajectory [7]. However,
there are indications children often do not receive
supportive care when dying, among which care at the
end of life. A recent systematic review indicated almost
half of children with cancer did not receive palliative
care at the end of life [8], even though palliative care is
indicated to improve patient outcomes [9, 10]. Children
tend to receive intense aggressive care in the last weeks
of life [11–14], while symptom control for pain, fatigue,
and dyspnea has been shown to be insufficient [5].
Increased attention for supportive care measures for
children in recent decades may have spurred improve-
ment: a 1997–2004 US follow-up cohort of children
suffered less from pain and dyspnea than a cohort from
1990 to 1997, possibly due to improvement in end-of-
life care management for children [5]. Nevertheless,
various studies have reported ongoing issues for children
at the end of life such as low accessibility to pediatric
palliative care services [15], lack of communication
between care professionals [16], insufficient resources
and training [17], and absence of children-specific qua-
lity measures [11, 18]. Children globally lack access to
supportive care measures [19], and while low access to
palliative care is associated in general with low-income
countries [20, 21], also high-income countries such as
Canada can struggle with accessibility to supportive care
due to, e.g., wide geography [22]. Challenges for support-
ive care for children at the end of life differ overall
between high-, middle-, and low-income countries, with
low-income country challenges often relating to the lack
of resources and finances, and high-income countries
focusing on improvement and continuity of care [22].
To further improve quality of life at the end of life for
seriously ill children, we need more insight into the
health interventions that influence quality of life at the
end of life. However, there is a lack of knowledge about
what health interventions, e.g., medication or palliative
care, can influence quality of life at the end of life
exactly, e.g., outcomes such as pain or anxiety. Knowing
what health interventions are appropriate and inappro-
priate will enable the development of quality indicators
of this care. Quality indicators are measurable items
referring to the outcomes, processes, or structure of
care. They can be used to monitor, assess, benchmark,
and eventually improve appropriate and inappropriate
end-of-life care for children. Multiple quality indicators
were already established for adult end-of-life care, and
one such indicator for inappropriate care for cancer
patients is a blood transfusion in the last month
before death [23].
A first step in developing validated sets of quality indi-
cators is to systematically review the literature describing
the health interventions that influence quality of life in
seriously ill children at the end of life. To our know-
ledge, there is no systematic overview to date of known
health interventions that have an influence—whether
negative, neutral, or positive—on quality of life at the
end of life in children’s care. Available reviews in
seriously ill children are limited in that they mainly focus
on health interventions and associated quality-of-
life outcomes in a curative phase, but not terminal or
end-of-life phase [3, 24, 25], or they focus only on the
association between one health intervention and quality
of life, such as the identification of benefits of specialized
pediatric palliative care services [4] and do not provide
an overview of other health interventions at the end of
life. Individual studies of various health interventions
and associations or impact on quality of life at the child’s
end of life are available but have not yet been systematic-
ally reviewed, summarized, or assessed for quality or
bias. This makes it difficult to scan the entire body of
evidence for quality, gaps, and effects for subgroups. For
instance, the influence of health interventions could
differ in terms of disease and age—differences are
likely to arise between cancer patients and those suf-
fering of neurological disorders, or between toddlers
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and teenagers. Therefore, we will conduct this com-
prehensive systematic review on the influence of vari-
ous health interventions for seriously ill children at
the end of life, identifying all available evidence that
associates health interventions with quality of life at
the end of life in seriously ill children in quantitative
empirical designs. The results of the systematic review
will become one pool of candidate quality indicators
from which final quality indicators will be chosen and
face-validated using the RAND/UCLA (Research ANd
Development corporation/University of California Los
Angeles) Appropriateness Method, a modified Delphi
panel method.
This study protocol has drawn upon the Preferred
Reporting Items for Systematic Review and Meta-Analysis
Protocols (PRISMA-P) guidelines for the reporting of
systematic review protocols. Any updates will be pro-
vided through the PROSPERO registry of systematic
reviews.
Methods
Concepts and definitions
For the purpose of the present study, the following defi-
nitions will be used: (1) quality of life is defined as all
measures or proxies of quality of life, care, or dying at
the end of life, containing six domains (physical health,
psychological health, independence level, social relations,
environment, spirituality/religion/personal beliefs [26]);
(2) a health intervention is any “act performed for, with
or on behalf of a person or population whose purpose is
to assess, improve, maintain, promote or modify health,
functioning or health conditions” [27] which also in-
cludes decisions about treatment, place of care, place of
death, etc.; (3) seriously ill children are defined as
people, who are suffering from a progressive life-
threatening disorder, excluding acutely ill children at the
end of life, i.e., those whose illness is due to trauma, sui-
cide, or other unforeseen complications not related to a
syndrome or illness; and (4) end of life is the period pre-
ceding the death of the child during the last months,
weeks, or days. To maximize the sensitivity of our search,
we will not delineate a cut-off point in months or days for
the end-of-life period, nor will we define a finite group of
disorders for the same reason.
Eligibility criteria
Study design
Inclusion We will include all quantitative empirical stu-
dies that measure the influence of a health intervention
on quality of life or proxies for quality of life affecting
more than 1 child.
We will include interventional, observational, and survey
designs. We will include the following types of inter-
ventional designs: pre-post study designs, non-randomized
trials, and randomized controlled trials. Observational
designs cannot show a causal relationship between an
intervention and quality-of-life outcome, yet by showing
associations can provide indications for the evaluation of
interventions in a field where evidence is scarce. Therefore,
the following types of observational designs will be in-
cluded: cohorts, case-control designs, and cross-sectional
designs. Lastly, we will include survey designs with quan-
tifiable results (e.g., measured on a Likert scale). Both
prospective and retrospective designs will be included.
Exclusion We will exclude protocol papers, meta-analyses,
literature reviews, studies with a single case design, quali-
tative research, and gray literature. Meta-analyses and
reviews will be excluded because the individual studies
should already appear in our selection. Qualitative and
gray research will be excluded because the review of
qualitative and gray literature requires different selec-
tion and evaluation criteria that we believe are better
discussed in a separate review.
Population
Inclusion We will include all publications that aim to
study children at the end of life. The publication should
include more than one seriously ill child equal to or be-
tween 1 and 17 years, a mean or median age equal to
or between 1 and 17 years for a group of seriously ill
children when no individual ages are provided, or ad-
dress seriously ill children in general by means of terms
such as “children,” “adolescents,” “Pediatric Intensive
Care Unit,” or other terms relating to children, and de-
scribe them with terms such as “terminal,” “seriously ill,”
“near death,” “dying,” or other medical terms indicating
the end of life. Children’s age will not have to be men-
tioned in the title or abstract for a study to be eligible
for selection. When it is unclear if the population is at
the end of life, this will be discussed between reviewers,
and if necessary, a pediatrician involved in the project
will decide whether the population is at the end of life.
Intervention or exposure
Inclusion We will include all publications that assess at
least one health intervention—e.g., medication, treat-
ments, programs (trials, Advanced Care Planning; pallia-
tive and psychosocial care; decisions on source of care,
place of care, place of death)— provided to the child at
the end of life, indicated explicitly by terms such as “end
of life,” “dying” or similar phrases, or medical terms indi-
cating end of life.
Outcome
Inclusion We will include all publications with at least
one proxy of quality of life akin to symptom assessment,
relief, or intensity; treatment burden, intensity, or
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toxicity; disability and psychosocial status; adverse symp-
toms; and perceptions on quality of life of the child.
Exclusion We will exclude all outcomes akin to demo-
graphics, health resource use, conformity to guidelines,
quality of life of the parent, medical staff, or people
involved other than the child. These measures will be
excluded as the measures are conceptually too remote
from the concept of quality of life, even if the publi-
cation itself indicates the measure as a proxy. These
measures will not be excluded when they are present in
the form of interventions, but only when they appear in
the form of quality-of-life outcomes, i.e., as a proxy of
quality of life of the child.
Outcomes that are not mentioned here and initiate a
discussion between the reviewers will be discussed be-
tween the reviewers, and if necessary, with a third
reviewer.
Other
Inclusion We will include all publications
1. Published from 1/1/2000 onwards. Papers before
2000 will not be included as practices before 2000
are likely to differ considerably from contemporary
practices, due to the ongoing developments in
children’s care, palliative care, and general medicine.
We based our choice of cut-off on the emergence
of the first research on pediatric palliative care [28].
Pediatric palliative and end-of-life care is a recently
emerging field and attention was only brought to
the pressing issues children at the end of life face
from 2000 onwards. Not only is there hardly any lit-
erature available on the topic before 2000, but we
also believe an increased awareness with regard to
pediatric palliative care signals a different medical
climate and should therefore not be part of the
evidence base we are constructing to underlie
quality indicators for our current medical care
system that is much more sensitive to supportive
care measures.
2. With the title and abstract published in English.
Full texts in other languages than English, Dutch,
French, and German will be translated by a native
speaker when needed. No language restrictions
were imposed.
Systematic search
Search strategy
The search strategy will be structured around four dis-
tinct blocks: population (children), care at the end of life,
quality of life at the end of life, and design of the study.
The PubMed database and syntax will be used as a
starting point for construction and validation. For
construction, the search blocks will be based on previous
search filters, some validated, as well as Medical Subject
Headings (MesH) terms and free text words. Experts on
care for children at the end of life (i.e., the authors of
the review) as well as relevant papers resulting from a
scoping review will be consulted for MesH terms and
relevant free text words to augment and/or refine the
strategy. The iterative process of construction will be
guided and checked by an information specialist. The
help of an information specialist, who in our case is spe-
cialized in the development of search strategies, database
searches, and systematic review methodology among
other things, is crucial in constructing and revising a
search strategy. Information specialists or professionals
have special knowledge in quality health information re-
sources. They have a direct impact on the quality of pa-
tient care, helping physicians, allied health professionals,
administrators, students, faculty, and researchers stay
abreast of and learn about new developments in their
fields. Using materials and tools that range from trad-
itional print journals to electronic databases and the lat-
est mobile devices, information specialists use innovative
strategies to access and deliver important information
for patient care, research, and publication. The informa-
tion professional might have a library background/edu-
cation or might have a health profession or researcher
background. An information specialist will provide guid-
ance and support in all steps of a systematic review in-
cluding the construction of a very sensitive search
strategy for this systematic review.
For validation of the search strategy, a validation set of
records will be constructed by hand-searching six
volumes of pediatric medical journals between 2000 and
2018 that adhere to our eligibility criteria by two
reviewers to obtain a gold standard. The six volumes will
be picked randomly using Excel.
The PubMed search strategy will be translated to the
other databases in collaboration with an information
specialist. Independent information specialists will peer-
review the strategies by email correspondence.
A preliminary version of the validated search strategy,
reference set, and validation set for MEDLINE using
PubMed are available in the additional documents (see
Additional files 1 and 2). The search strategy adheres to
the Peer Review of Electronic Search Strategies (PRESS)
criteria for electronic search strategies as stated in the
2015 Guideline Statement [29].
Sources
The systematic search will be conducted in MEDLINE
(using the PubMed interface), Embase (using the em-
base.com interface), CENTRAL, CINAHL (using the
EBSCO interface), and Web of Science.
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Publication selection
Papers will be selected by three independent researchers,
following Cochrane guidelines to reduce bias with a
two-step screening process. When a publication is iden-
tified as potentially relevant, based on its title and/or
abstract, by the eligibility criteria described above, a full-
text review will be done by the same three independent
authors applying the same eligibility criteria. If dis-
crepancies should arise between assessors, they will be
resolved by consensus. An additional author will be
consulted in cases where no agreement between the two
assessors can be reached. The online software program
Covidence will be used to keep track of the selection
process, which was developed by the Cochrane founda-
tion explicitly for the use of systematic reviews, to up-
load all references of selected articles via Endnote and
extract all titles, abstracts, and pdfs. It allows to easily
keep track of exclusion and inclusion by all reviewers.
For the full-text review, we will look for the selected
articles online, utilise our university library services to
obtain articles requiring subscription, and/or contact
colleagues and authors to obtain the full text. When no
full text of the article can be obtained this way, the
record will be excluded. In accordance with the PRISMA
guidelines [30], the rationale for rejection of each paper
will be recorded during the full-text review phase. The
reference lists of all identified publications will then be
screened for additional relevant publications. The corre-
sponding author of each publication and known experts
in the field of care for children at the end of life will be
contacted for possible additional publications eligible for
inclusion. Assessment for the inclusion of included
papers in a possible meta-analysis will be done in-
dependently by the same three reviewers.
Data extraction and quality assessment
Data extraction
A pilot-tested data extraction form will be used to
systematically extract data. The extraction form will be
tested with two studies by two reviewers prior to the full
extraction process. Discrepancies will be resolved through
discussion between two reviewers and, when necessary, by
consulting an additional co-author reviewer. The follow-
ing data will be extracted by one researcher, with a 20%
sample reviewed by another researcher: title; authors; date
of publication (month, day); year of publication; journal;
country (where data collection took place); aim/research
question(s) (as stated in the study); start and end of inter-
vention or exposure (in days before death); duration of
intervention (in days); setting (where health intervention
took place); population; participants (who + number);
children’s age (mean, median, range, and/or interquartile
range (IQR)); children’s age group (0–1, 1–5, 6–9, 10–14,
15–17, 18+); children’s illness (as stated in the study);
children’s illness category (cancer, neurological disorder,
or other); language of article; definition of end of life; in-
dications of end of life throughout the article; reported
health intervention(s) and quality of life; measurement of
the health intervention; measurement of quality of life
(proxy); definer of quality of life (proxy); study design;
quality score based on the QualSyst tool (as described
below); reported influence of health intervention; avail-
ability of separate results for target age group; and avail-
ability of separate results for children at the end-of-
life stage.
Risk of bias and quality assessment
The quality of each individual study will be assessed with
the QualSyst checklist for assessing the quality of quan-
titative studies. The 14-item checklist will be used to
assess research questions and objectives, study design,
subject and comparison group selection and characteris-
tics, interventional allocation, definitions of outcomes,
sample size, analytic methods, confounding, and reports
of results. We will calculate interrater agreement between
the reviewers for a 20% sample. For assessment of the full
body of evidence, i.e., for each intervention and outcome,
we will utilize the Grading of Recommendations Assess-
ment (GRADE) approach [31]. GRADE is a step-wise
method to assess the certainty of evidence in the synthesis
of scientific literature, such as reviews and guidelines,
and is commonly used for the appraisal of effects
found of health interventions in health care and the
public health domain. The method is used to rate
evidence per outcome and starts with a high rating
for RCTs and low rating for all other study designs.
Eight criteria, such as risk of bias or large magnitude
of effect, are then used to either upgrade or down-
grade the final rating to high, moderate, low, or very
low quality of evidence. This way, the method can
indicate how certain we can be of an effect and whether
reliable recommendations for practice in health care can
be made based on the evidence that is available.
The QualSyst tool will be used to obtain a quality
assessment of each study, and the GRADE approach will
then be used to grade the quality of the body of evidence
for each health intervention.
One reviewer will carry out full data extraction and
quality assessment (QualSyst and GRADE), and a 20%
random sample will be extracted and assessed by two
independent reviewers. Discrepancies will be resolved
through consensus with a third reviewer.
Data synthesis
We will create an overview table of all health inter-
ventions and associated quality of life-related outcomes at
the end of life in children. We will include health inter-
vention, health intervention category (e.g. medication,
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treatment), quality-of-life outcome, quality-of-life category
(physical health, psychological health, independence level,
social relations, environment, spirituality/religion/personal
beliefs [26]); the number of studies (by health intervention
and quality-of-life outcome); definer(s), age group; disease
group; timing before death in days; reported influence (de-
scriptive); whether or not the influence on the quality of
life of other persons involved was measured as well;
GRADE score; and additional comments.
Statistical analysis
A meta-analysis will be performed if sufficient homoge-
neous studies of similar outcome, design and measure
are found. As we expect to find a variety of health inter-
ventions as well as a variety of quality of life-related out-
comes, two independent reviewers will first discuss
clinical and methodological heterogeneity for all similar
health interventions. The two reviewers will discuss
outcomes and their methodology for all similar health
interventions with two or more outcomes. Clinical and
methodological heterogeneity will be assumed when a
different quality-of-life outcome is assessed for the same
intervention in terms of symptomology (e.g., pain versus
anxiety) or when a different measurement is used for the
outcome (e.g., pain scale versus nurse evaluation of
pain). If clinical and methodological homogeneity is
present, we will assess statistical heterogeneity. Statistical
heterogeneity will be assessed with the chi-squared (χ2)
test and inconsistency index (I2). In agreement with the
Cochrane Collaboration threshold recommendations for
the assessment of heterogeneity, we will not perform
meta-analysis when p value is below 0.1 or the I2 statistic
is higher than 75% [32]. If no statistical heterogeneity
seems to be present, we will perform a random effects
model with a 95% confidence interval. If more than ten
studies measure similar outcomes and interventions,
sensitivity analyses will be conducted to examine the
robustness of results resulting from meta-analysis. To
do so, we will conduct separate meta-analyses without
the studies with high risk of bias (selection based on
GRADE) and will compare these analyses with the
meta-analysis with all studies included regardless of risk of
bias. In case more than ten studies assessing the same
quality-of-life outcome for a similar health intervention
are available, publication bias will be evaluated using a
funnel plot, assessing plot symmetry of the available
effects. If sufficient age and disease characteristics are
given within the studies used for meta-analysis, numerical
subgroup analyses will be done for these factors. Data for
subgroup analyses will be obtained from demographic
data included in the study.
We will use the Cochrane meta-analysis software
Review Manager 5 (Revman 5) for all meta-analysis calcu-
lations. Outcomes are expected to be continuous as well
as dichotomous. We will report continuous outcomes as
means, the difference in means, and their 95% confidence
intervals. When mean is not given, other summary sta-
tistics available such as median will be reported. We will
report dichotomous outcomes as odds ratios or per-
centages, and their 95% confidence intervals.
In case no meta-analysis is possible, a narrative synthe-
sis will be done, in which we will include a discussion of
relevant factrs such as age, disease group, and definers
of quality of life.
Discussion
To our knowledge, no systematic review of studies has
yet been conducted that looks into the influence of
health interventions on quality of life at the end of life in
seriously ill children. This systematic review will add to
the construction of a reliable and valid evidence base to
be utilized in children’s end-of-life research and in health
care policy to improve quality of life and care. As part of
a larger project on quality indicators, the review is a
primary step in the construction of a set of quality indi-
cators for care for children at the end of life for multiple
disease groups, pending face-validation, and expert
consensus. Quality indicators are regarded as a valid tool
to monitor care standards with the use of population-
level data [33]. We will apply the quality indicators to
population-level data for deceased seriously ill children
in Flanders and compare results on quality indicators
for the different populations, settings, and regions.
Additionally, we will benchmark care between different
health regions for all indicators to set performance
standards and norms that can eventually lead to actual
improvement of care. This review protocol is published to
allow other researchers to compare previously established
methods to the final review, promoting quality adher-
ence, and to facilitate future updates of the review to
keep quality indicators up-to-date by identifying any
new potential quality indicators arising in future quan-
titative empirical studies.
Expected limitations of the review are differences in
patient and disease characteristics, and the exclusion of
qualitative studies and process- and structure-related out-
comes. Care for children at the end of life is a hetero-
geneous field in terms of disease etiology, progression,
and age—for instance, the developmental gap between
young children and adolescents is likely to lead to diffe-
rences in the influence of health interventions. Due to
limited patient availability, study samples are often likely
to contain children with various etiologies and in various
disease stages. We will ensure subgroup analyses in our
narrative and numerical analyses whenever possible. Our
exclusion criteria omit qualitative studies and process-
and structure-related quality-of-life outcomes, and this
omission may bias the evaluation of the evidence base.
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However, we believe the analysis of the qualitative studies
requires a distinctly different approach than the analysis
of the quantitative studies, and systematic reviews are
regularly limited to the synthesis of quantitative papers.
As quantitative outcomes will already provide sufficient
material for synthesis, qualitative studies are therefore
better discussed and synthesized in a separate study. We
acknowledge, however, that the addition of qualitative
designs can only broaden our understanding of the
current evidence base of the influence of health interven-
tions on quality of life in seriously ill children, and there-
fore, we plan on conducting an additional scoping review
that summarizes outcomes found in qualitative studies.
We urge that process and structure outcomes be looked
into systematically as well, as these outcomes could also
significantly implicate end-of-life care in children at the
end of life.
Additional files
Additional file 1: Reference and validation set for construction of the
MEDLINE search strategy.
Additional file 2: Search strategy for MEDLINE (PubMed interface).
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